Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex
Tranylcypromine (TCP) is a commercially available antidepressant drug, and recent literature reports suggest that high doses of this drug may be particularly effective in treating refractory depression. Down-regulation of 5-HT2 receptors in rat cortex is an effect produced after chronic administration of several antidepressants, and we have conducted a chronic study comparing low- and high-dose TCP in this regard. Male Sprague-Dawley rats were administered TCP (0.5 or 2.5 mg/kg/day) or vehicle (distilled water) via Alzet minipumps implanted subcutaneously in the dorsal thoracic area. Groups of rats were killed 4, 10 or 28 days after pump implantation and whole cortex was dissected out and utilized for preparation of a membrane fraction. Binding studies were performed with this fraction using 3H-ketanserin as the radioligand. Down-regulation (decrease in Bmax) of the 5-HT2 binding site was observed in high-dose animals after 10 and 28 days but not after 4 days. Low-dose TCP had no effect on 5-HT2 densities at any time interval. The affinity of 3H-ketanserin for the 5-HT2 site was not affected by either dose at any time interval. These results suggest that down-regulation of the 5-HT2 site may contribute to the efficacy of high-dose TCP in the treatment of refractory depression.
KeywordsMonoamine Oxidase Inhibitor Drug Treatment Group Antidepressant Efficacy Refractory Depression Bioi Psychiatry
Unable to display preview. Download preview PDF.
- Baker GB, Hiob LE, Dewhurst WG (1980) Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytrypamine from rat striatum in vitro. Cell Mol Biol 26: 182–186.Google Scholar
- Baker GB, McKim HR, Calverley DG, Dewhurst WG (1978) Effects of the monoamine oxidase inhibitors tranylcypromine, phenelzine, and pheniprazine of the uptake of catecholamines in slices from rat brain regions. Proc Eur Soc Neurochem 1: 536.Google Scholar
- Baker GB, Greenshaw AJ (1989) Effects of long-term administration of antidepressants on receptors in the central nervous system. Cell Mol Biol 9: 1–44.Google Scholar
- Ferris RM, Howard JL, White HL (1975) A relationship between clinical efficacy and various biochemical parameters of monoamine oxidase inhibitors (MAOIs). Pharmacologist 17: 451.Google Scholar
- Giller EG, Lieb J (1980) Monoamine oxidase inhibitors and platelet monoamine oxidase inhibition. Comm Psychopharmacol 4: 79–82.Google Scholar
- Goodnough DB, Baker GB (1993) Tranylcypromine does not enhance the effects of amitriptyline on 5-HT2 receptors in rat brain. J Pharm Sci (in press).Google Scholar
- Goodnough DB, Baker GB, Mousseau DD, Greenshaw AJ, Dewhurst WG (1994) Effects of low-and high-dose tranylcypromine on [3H]-tryptamine binding sites in the rat hippocampus and striatum. Neurochem Res (in press).Google Scholar
- Lafaille F, Welner SA, Suranyi-Casotte BE (1991) Regulation of serotonin type 2 (5-HT2) and β-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment. J Psychiatr Neurosci 16: 209–214.Google Scholar
- Robinson DS, Nies A, Ravaris CL, Ives JO, Barlett D (1978) Clinical pharmacology of phenelzine: MAO activity and clinical response. In: Lipton M, Dimascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York.Google Scholar
- Robinson DS (1983) High-dose monoamine oxidase-inhibitor therapy. J Am Med Assoc 250: 2212.Google Scholar